PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Comorbidity diseases in adults with diagnosed interstitial lung diseases among inhabitants of the Silesian voivodeship, Poland.

Abstract Interstitial lung diseases form a group of chronic diseases associated with a significant worsening of the quality of life. Proper management of these diseases involves the recognition and treatment of comorbidities, so it implies high direct and indirect costs of therapy. The lack of epidemiological data on the total incidence of interstitial diseases in Poland, as well as of information on their increasing incidence in other European countries justify investigations into epidemiological situation in the Silesian voivodeship (the southern region of Poland).
PMID
Related Publications

Epidemiology of diabetes type 1 in children aged 0-14 in Podlasie Province in years 2005-2012.

Health state assessment in people sentenced to the penalty of restriction of liberty.

Challenges to occupational medicine in view of the problem of work-related diseases and the aging of workforce. Directions for further development and intentional changes in preventive care of employees in Poland.

Occurrence of occupational diseases in Poland, 2014.

Heart disease attributed to occupational noise, vibration and other co-exposure: Self-reported population-based survey among Bulgarian workers.

Authors

Mayor MeshTerms
Keywords

coexisting diseases

drug-induced and iatrogenic pulmonary fibrosis

epidemiological descriptive study

idiopathic pulmonary fibrosis

interstitial lung disease

sarcoidosis

Journal Title medycyna pracy
Publication Year Start




PMID- 28005084
OWN - NLM
STAT- MEDLINE
DA  - 20161222
DCOM- 20170313
LR  - 20170313
IS  - 0465-5893 (Print)
IS  - 0465-5893 (Linking)
VI  - 67
IP  - 6
DP  - 2016 Dec 22
TI  - [Comorbidity diseases in adults with diagnosed interstitial lung diseases among
      inhabitants of the Silesian voivodeship, Poland].
PG  - 751-763
LID - 63036 [pii]
LID - 10.13075/mp.5893.00487 [doi]
AB  - BACKGROUND: Interstitial lung diseases form a group of chronic diseases
      associated with a significant worsening of the quality of life. Proper management
      of these diseases involves the recognition and treatment of comorbidities, so it 
      implies high direct and indirect costs of therapy. The lack of epidemiological
      data on the total incidence of interstitial diseases in Poland, as well as of
      information on their increasing incidence in other European countries justify
      investigations into epidemiological situation in the Silesian voivodeship (the
      southern region of Poland). MATERIAL AND METHODS: In a descriptive study
      registered data provided by the National Health Found in 2006-2010 were used to
      assess the temporal variability of standardized incidence rates. A data set
      included interstitial lung diseases and comorbidities in adults aged >/= 19
      years, residents of the Silesian voivodeship. RESULTS: In the period under study 
      standardized incidence ratios for interstitial lung disease declined from 9.7/100
      000 adult population to 7.8/100 000 adult population. The most prevalent
      comorbidities included cardio-vascular diseases, chronic and infectious
      respiratory diseases, metabolic diseases and musculoskeletal and connective
      tissue diseases. Comorbidities were found more frequently in older people >/= 65 
      years, except for sarcoidosis, which was four times more prevalent in younger
      people (19-64 years) compared to older patients. The estimated costs of treatment
      of the analysed diseases reached more than 50 mln zlotys (12 mln dollars) per
      year. CONCLUSIONS: A small but systematic decrease in the value of the
      standardized incidence rate for interstitial lung disease has been shown within
      the range of 9.7-7.8/100 000 adult inhabitants. The most frequent comorbidities
      included cardiovascular or chronic and infectious respiratory diseases. The high 
      cost of therapy of interstitial lung diseases was largely related to simultaneous
      treatment of comorbidities. Med Pr 2016;67(6):751-763.
FAU - Niewiadomska, Ewa
AU  - Niewiadomska E
AD  - Slaski Uniwersytet Medyczny w Katowicach / Medical University of Silesia,
      Katowice, Poland (Wydzial Zdrowia Publicznego w Bytomiu, Katedra Epidemiologii i 
      Biostatystyki / School of Public Health in Bytom, Department of Epidemiology and 
      Biostatistics). [email protected]
FAU - Kowalska, Malgorzata
AU  - Kowalska M
AD  - Slaski Uniwersytet Medyczny w Katowicach / Medical University of Silesia,
      Katowice, Poland (Wydzial Lekarski w Katowicach, Katedra i Zaklad Epidemiologii /
      School of Medicine in Katowice, Department of Epidemiology).
      [email protected]
FAU - Zejda, Jan E
AU  - Zejda JE
AD  - Slaski Uniwersytet Medyczny w Katowicach / Medical University of Silesia,
      Katowice, Poland (Wydzial Lekarski w Katowicach, Katedra i Zaklad Epidemiologii /
      School of Medicine in Katowice, Department of Epidemiology). [email protected]
LA  - pol
PT  - Journal Article
TT  - Choroby wspolistniejace w przypadku srodmiazszowych chorob pluc u doroslych
      mieszkancow wojewodztwa slaskiego.
DEP - 20161122
PL  - Poland
TA  - Med Pr
JT  - Medycyna pracy
JID - 0376642
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Cardiovascular Diseases/epidemiology
MH  - Comorbidity
MH  - Female
MH  - Humans
MH  - Infection/epidemiology
MH  - Lung Diseases, Interstitial/diagnosis/*epidemiology
MH  - Male
MH  - Middle Aged
MH  - Occupational Diseases/diagnosis/*epidemiology
MH  - Occupational Exposure/statistics & numerical data
MH  - Poland/epidemiology
MH  - Prevalence
MH  - Young Adult
OAB - Publisher: WSTEP: Srodmiazszowe choroby pluc to grupa chorob przewleklych
      wplywajaca na znaczne pogorszenie jakosci zycia. Postepowanie terapeutyczne w
      przypadku tych chorob wymaga takze rozpoznania i leczenia chorob
      wspolistniejacych, dlatego jest obarczone wysokimi kosztami bezposrednimi i
      posrednimi. Brak danych epidemiologicznych dotyczacych czestosci wystepowania
      chorob srodmiazszowych w naszym kraju, jak rowniez doniesienia o rosnacej
      zapadalnosci w innych krajach europejskich uzasadniaja poznanie sytuacji
      epidemiologicznej w odniesieniu do tych chorob, z uwzglednieniem chorob
      wspolistniejacych. MATERIAL I METODY: Na podstawie danych rejestrowych z lat
      2006-2010, udostepnionych przez Narodowy Fundusz Zdrowia (NFZ), oceniono czasowe 
      zroznicowanie standaryzowanych wspolczynnikow opisujacych liczbe nowych
      zachorowan oraz przedstawiono strukture chorob wspolistniejacych. Dane dotyczyly 
      mieszkancow wojewodztwa slaskiego w wieku >/= 19 lat. WYNIKI: Wykazano niewielki,
      lecz systematyczny, spadek wartosci standaryzowanego wspolczynnika zachorowan na 
      srodmiazszowe choroby pluc w zakresie 9,7-7,8/100 000 doroslych mieszkancow.
      Wsrod chorob wspolistniejacych dominowaly choroby ukladu krazenia, przewlekle i
      zakazne choroby ukladu oddechowego, choroby metaboliczne oraz choroby ukladu
      miesniowo- -szkieletowego i tkanki lacznej. Choroby towarzyszace wystepowaly
      czesciej wsrod osob starszych (>/= 65 lat), z wyjatkiem sarkoidozy, w ktorej
      przypadku liczba rejestrowanych chorob wspolistniejacych byla 4-krotnie wieksza u
      mlodszych osob (19-64-letnich). Koszty leczenia wybranych chorob ukladu
      oddechowego w wojewodztwie slaskim siegaja ponad 50 mln zlotych rocznie. WNIOSKI:
      Wykazano niewielki spadek wartosci standaryzowanego wspolczynnika zachorowan na
      srodmiazszowe choroby pluc u doroslych mieszkancow wojewodztwa slaskiego. Wsrod
      najczesciej rejestrowanych chorob wspoltowarzyszacych znajduja sie choroby ukladu
      krazenia oraz przewlekle i zakazne choroby ukladu oddechowego. Wysokie koszty
      terapii chorob srodmiazszowych sa m.in. skutkiem leczenia chorob
      wspolistniejacych. Med. Pr. 2016;67(6):751-763.
OABL- eng
OTO - NOTNLM
OT  - *coexisting diseases
OT  - *drug-induced and iatrogenic pulmonary fibrosis
OT  - *epidemiological descriptive study
OT  - *idiopathic pulmonary fibrosis
OT  - *interstitial lung disease
OT  - *sarcoidosis
EDAT- 2016/12/23 06:00
MHDA- 2017/03/14 06:00
CRDT- 2016/12/23 06:00
AID - 63036 [pii]
AID - 10.13075/mp.5893.00487 [doi]
PST - ppublish
SO  - Med Pr. 2016 Dec 22;67(6):751-763. doi: 10.13075/mp.5893.00487. Epub 2016 Nov 22.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>